electroCore Completes Acquisition of NeuroMetrix, Gaining Access to its Quell Platform, Creating Significant Player in Non-Invasive Bioelectronic TechnologiesGlobeNewsWire • 05/02/25
electroCore to Announce First Quarter March 31, 2025 Financial Results on Wednesday, May 7, 2025GlobeNewsWire • 04/30/25
gammaCore Non-Invasive Vagus Nerve Stimulation (nVNS) Shown to be Effective in Treating Concussive Symptoms Associated with Mild Traumatic Brain InjuriesGlobeNewsWire • 04/17/25
electroCore Named One of The Americas' Fastest Growing Companies by the Financial TimesGlobeNewsWire • 04/03/25
electroCore to Announce Fourth Quarter and Full Year Ended December 31, 2024 Financial Results on Wednesday, March 12, 2025GlobeNewsWire • 03/06/25
electroCore, Inc. Announces Agreement with Spark Biomedical Inc. to Distribute Sparrow Ascent for Opioid WithdrawalGlobeNewsWire • 02/27/25
electroCore (ECOR) Is a Great Choice for 'Trend' Investors, Here's WhyZacks Investment Research • 02/12/25
electroCore to Participate at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools ConferenceGlobeNewsWire • 02/04/25
electroCore to Acquire NeuroMetrix, Gaining Access to its Quell Platform and Positioning Itself as a Significant Player in Non-Invasive Bioelectronic Medicine and WellnessGlobeNewsWire • 12/17/24
electroCore to Participate at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum on November 21GlobeNewsWire • 11/14/24